4 February 2023 in General Reanimatology
Materials and methods. This study analyzed the results of treatment of 62 patients with severe COVID-19 in the intensive care unit using selective hemoadsorption of cytokines. All patients with severe COVID-19 were admitted to the intensive care unit within 14 days from the disease onset were subdivided into two groups. Group 1 patients (n=32) received on a top of standard treatment the hemoperfusion (HP) procedure for 4 hours, for 2–3 days in a row, using a cytokine sorption column composed of mesoporous styrene-divinilbenzen copolymer matrix. Group 2 patients were not subjected to extracorporeal blood purification. All patients received IL-6 inhibitors at a baseline in accordance to the temporary guidelines. We evaluated factors of unfavorable outcomes by analyzing changes in biochemical markers of systemic inflammatory response and mortality rates in patients of both groups.Results. Initiation of HP later than 10 days from NCI onset (P < 0.001), length of stay in the ICU, extent of lung damage (P = 0.036) and the SOFA (Sequential Organ Failure Assessment) score (P = 0.009) were the most powerful predictors of unfavorable outcome. Levels of systemic inflammatory response markers (interleukin- 6, CRP, D-dimer) in both groups did not significantly affect the survival rates and length of hospital stay (P > 0.05). HP group demonstrated better survival (P < 0.05). Mean hospital stay was 31 and 27 days, ICU stay — 11 and 8 days for Groups 1 and 2, respectively (P < 0.05).Conclusion. Treatment of severe COVID-19 patients with HP using novel domestic hemosorbent composed of styrene-divinilbenzen copolymer matrix resulted in decrease in CRP levels on the first day after application and, with early onset, contributed to a significant increase in survival and decreased hospital and ICU stay. Additional studies are warranted to clarify the optimal timing of the initiation of HP in severe COVID-19 patients.
17 August 2023 in Terapevticheskii arkhiv
ЗНЗамятина Ксения Николаевна
Замятина Ксения Николаевна
+5
Aim. To evaluate the relationship between the systemic inflammatory response and the severity of COVID-19-associated endotheliopathy and the effect of succinate-containing crystalloid solution (sodium meglumine succinate) on it in patients with severe COVID-19. Materials and methods. Clinical and laboratory parameters of 53 intensive care unit's patients with COVID-19 complicated by community-acquired bilateral multisegmental pneumonia were analyzed. Intensive therapy complex of 27 patients (study group) included daily infusion of 1.5% solution of sodium meglumine succinate (Reamberin) in the daily dose of 10 ml/kg for at least 11 days (or during the whole stay in the unit). A similar volume of Ringer's solution was present in the control group of 26 patients. The levels of endotheliocytosis, homocysteine, and systemic inflammatory response were determined at all stages of the study. Results. The evaluation of endotheliopathy degree in the meglumine succinate group showed a significant reduction of initially elevated levels of endotheliemia and homocysteinemia at all study stages. The pattern of changes in the study group was highly correlated (r=0.900.96) with the dynamics of systemic inflammatory response parameters-fibrinogenemia, C-reactive protein and interleukin-6 levels. As normalization of the immune imbalance, we regarded the termination of lymphopenia in the Reamberin group. Conclusion. Early inclusion of Reamberin infusion into intensive therapy of severe COVID-19, in comparison with Ringer's solution, leads to significant and stable correction of the severity of systemic inflammatory response, which in turn is naturally reflected in the severity of endothelial dysfunction, multiple organ failure, and also leads to a decrease in 28-day mortality.
29 February 2024 in Russian Rhinology
Obstructive sleep apnea syndrome (OSAS) is the cause of serious disorders development in children. Polysomnography (PSG), which is considered a «gold» standard for apnea diagnosis, is often not available to patients because of financial, organizational and geographical aspects. How far can subjective examination methods replace PSG? Objective. Comparison of subjective data obtained with the Russian-language PSQ questionnaire and objective PSG results in children with suspicion of OSAS. Material and methods. A retrospective comparative analysis of the PSQ questionnaire survey results and PSG data in 126 children aged from 2 to 14 years has been conducted. Results. The sensitivity of the PSQ questionnaire was 83.9% and the specificity was 34.4% According to the analysis. A statistically significant correlation between the PSQ mean score and the apnea/hypopnea index was found. Conclusion. The Russian-language PSQ version showed a diagnostic significance in children with suspicion of OSAS.
31 January 2025 in General Reanimatology
Prevention of brain injury during carotid endarterectomy (CEA) remains a significant challenge. Moderate controlled systemic hypothermia may serve as a potential neuroprotective measure during these procedures.Aim of the study. To investigate the neuroprotective effects of moderate systemic hypothermia during CEA.Materials and methods. Fifty-nine patients undergoing CEA under combined anesthesia were included. Patients were divided into two groups: the hypothermia group (N=33) and the normothermia control group (N=26). Both groups received standard measures to prevent cerebral ischemia. The hypothermia group received additional moderate systemic hypothermia aimed at a temperature range of 34–35°C. Cognitive function was assessed preoperatively and at 2, 5, and 30 days postoperatively using neurocognitive tests. Statistical analysis was performed with IBM SPSS Statistics.Results. The incidence of cognitive impairment was 21.1% in the hypothermia group and 26.9% in the normothermia group. Postoperative cognitive impairment was more common in the normothermia group: 15.38% on day 5 and 11.5% on day 30 postoperatively compared to 12.1% and 6.1% in the hypothermia group (P<0.05).Conclusion. This study demonstrated the neuroprotective effects of hypothermia, manifested by a reduced severity of cognitive impairment in the hypothermia group. Further research is needed to identify high-risk patients who would benefit most from this neuroprotective strategy and to optimize hypothermia protocols.
20 December 2024 in HERALD of North-Western State Medical University named after I.I. Mechnikov
ЗПЗавьялова Татьяна Павловна
Завьялова Татьяна Павловна
+1
BACKGROUND: Early experience with succinate-containing agents has demonstrated their effectiveness in controlling COVID-19-related systemic disease and coagulopathy. The work is aimed at studying the possibilities of infusion correction of COVID-19-associated endotheliopathy. AIM: To evaluate the effect of using meglumine sodium succinate 1.5% solution on the severity of COVID-19-associated endotheliopathy in patients with severe coronavirus infection. MATERIALS AND METHODS: Clinical and laboratory parameters of 53 patients in the intensive care unit with COVID-19 complicated by community-acquired bilateral polysegmental pneumonia were analyzed. The intensive care package for 27 patients (study group) included a daily infusion of a 1.5% solution of meglumine sodium succinate (Reamberin) in a daily dose of up to 10 ml/kg for a course of at least 11 days or during the entire stay in the department. The control group, which included 26 patients, received a similar volume of Ringer’s solution. At all stages of the study, the level of endotheliocytosis, homocysteine, fibrinogen, activated partial thromboplastin time, platelet count, and antithrombin III was determined. RESULTS: Assessment of the degree of endotheliopathy in the meglumine succinate group showed a significant decrease in the initially elevated levels of endothelemia and homocysteinemia at all stages of the study. The pattern of changes in the study group highly correlated (r values were in the range 0.90–0.96) with the dynamics of fibrinogenemia, platelet levels, and antithrombin III. CONCLUSIONS: The use of a succinate-containing infusion solution in patients with a new coronavirus infection promotes a more rapid and sustainable correction of COVID-19-associated endotheliopathy, which, in turn, is manifested by a decrease in the levels of endotheliocytosis, secondary markers of endotheliopathy, a platelet-protective effect and a decrease in heparin resistance.
19 September 2024 in Russian Journal of Anesthesiology and Reanimatology
Objective. To evaluate the strategies and role of selective hemosorption of cytokines in the treatment of severe COVID-19 infection. Material and methods. Systematic searching for available literature data on selective hemosorption of cytokines in patients with COVID-19 was performed in the PubMed and Elibrary databases. Results. We found 264 articles according to keywords. Considering inclusion criteria, we enrolled 22 full-text articles. Of these, four manuscripts were selected to estimate the effect of isolated selective cytokine hemosorption. Three articles were selected to study the effect of hemosorption combined with renal replacement therapy. Conclusion. Heterogeneous data without control group in most studies and predominant small samples do not provide an opportunity to draw an unambiguous conclusion about clinical effect of various methods of efferent therapy. However, selective hemosorption of cytokines in the treatment of COVID-19 reduces mortality.